ASLAN Pharmaceuticals Lim...

NASDAQ: ASLN · Real-Time Price · USD
0.60
-0.10 (-14.27%)
At close: Jul 18, 2024, 10:00 PM

ASLAN Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-44.22M -51.28M -31.59M
Depreciation & Amortization
348.5K 331.75K 282.22K
Stock-Based Compensation
2.7M 1.98M 2.19M
Other Working Capital
1.91M -316.18K -4.92M
Other Non-Cash Items
6.03M 1.22M 1.86M
Deferred Income Tax
-8.27M n/a -2.62M
Change in Working Capital
-2.95M 9.35M -4.12M
Operating Cash Flow
-46.36M -38.41M -34M
Capital Expenditures
-10.78K -27.11K -48.81K
Cash Acquisitions
148.00 1.17K n/a
Purchase of Investments
n/a -16.51M n/a
Sales Maturities Of Investments
n/a 16.6M n/a
Other Investing Acitivies
n/a 353.14K 20.65K
Investing Cash Flow
-10.63K 414.7K -28.16K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
10.72M 4.72M 109.87M
Financial Cash Flow
10.72M 4.72M 109.87M
Net Cash Flow
-35.65M -33.27M 75.84M
Free Cash Flow
-46.37M -38.43M -34.04M